Penobscot Investment Management Company Inc. Has $676,000 Stock Position in Agilent Technologies, Inc. $A

Penobscot Investment Management Company Inc. trimmed its position in shares of Agilent Technologies, Inc. (NYSE:A) by 47.9% during the 1st quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 5,935 shares of the medical research company’s stock after selling 5,455 shares during the period. Penobscot Investment Management Company Inc.’s holdings in Agilent Technologies were worth $676,000 at the end of the most recent reporting period.

Several other large investors have also recently added to or reduced their stakes in A. Gabelli Funds LLC increased its holdings in Agilent Technologies by 1.1% in the third quarter. Gabelli Funds LLC now owns 6,620 shares of the medical research company’s stock worth $850,000 after buying an additional 74 shares during the last quarter. Fiduciary Trust Co increased its holdings in shares of Agilent Technologies by 1.6% during the 3rd quarter. Fiduciary Trust Co now owns 4,931 shares of the medical research company’s stock valued at $633,000 after acquiring an additional 77 shares during the last quarter. NorthCrest Asset Manangement LLC increased its holdings in shares of Agilent Technologies by 1.6% during the 4th quarter. NorthCrest Asset Manangement LLC now owns 5,082 shares of the medical research company’s stock valued at $726,000 after acquiring an additional 79 shares during the last quarter. Freestone Capital Holdings LLC raised its stake in shares of Agilent Technologies by 2.0% in the 4th quarter. Freestone Capital Holdings LLC now owns 4,218 shares of the medical research company’s stock valued at $574,000 after acquiring an additional 84 shares in the last quarter. Finally, Grove Bank & Trust raised its stake in shares of Agilent Technologies by 5.5% in the 4th quarter. Grove Bank & Trust now owns 1,758 shares of the medical research company’s stock valued at $239,000 after acquiring an additional 92 shares in the last quarter.

Analyst Ratings Changes

A has been the subject of a number of recent analyst reports. Piper Sandler began coverage on Agilent Technologies in a research report on Thursday, June 11th. They set a “neutral” rating and a $150.00 target price for the company. TD Cowen lifted their price target on shares of Agilent Technologies from $147.00 to $155.00 and gave the company a “buy” rating in a research report on Thursday, May 28th. Wolfe Research reiterated a “hold” rating on shares of Agilent Technologies in a research note on Tuesday, June 2nd. Barclays lifted their target price on shares of Agilent Technologies from $145.00 to $150.00 and gave the stock an “overweight” rating in a report on Wednesday, June 24th. Finally, Weiss Ratings upgraded shares of Agilent Technologies from a “hold (c-)” rating to a “hold (c)” rating in a report on Tuesday, June 2nd. Two research analysts have rated the stock with a Strong Buy rating, thirteen have assigned a Buy rating and three have given a Hold rating to the stock. According to data from MarketBeat.com, Agilent Technologies currently has a consensus rating of “Moderate Buy” and an average target price of $160.88.

Agilent Technologies Stock Down 1.8%

Shares of NYSE:A opened at $128.77 on Thursday. The company has a debt-to-equity ratio of 0.43, a quick ratio of 1.62 and a current ratio of 2.10. The company has a market capitalization of $36.37 billion, a PE ratio of 25.86, a P/E/G ratio of 2.33 and a beta of 1.25. Agilent Technologies, Inc. has a 52 week low of $108.35 and a 52 week high of $160.27. The company’s fifty day moving average is $124.91 and its 200-day moving average is $125.73.

Agilent Technologies (NYSE:A) last posted its quarterly earnings data on Wednesday, May 27th. The medical research company reported $1.49 earnings per share for the quarter, beating the consensus estimate of $1.41 by $0.08. The firm had revenue of $1.83 billion during the quarter, compared to analysts’ expectations of $1.80 billion. Agilent Technologies had a net margin of 19.55% and a return on equity of 24.33%. The company’s quarterly revenue was up 10.0% compared to the same quarter last year. During the same quarter last year, the company posted $1.31 EPS. Agilent Technologies has set its FY 2026 guidance at 6.000-6.100 EPS and its Q3 2026 guidance at 1.480-1.500 EPS. Equities research analysts predict that Agilent Technologies, Inc. will post 6 earnings per share for the current fiscal year.

Agilent Technologies Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Wednesday, July 22nd. Stockholders of record on Tuesday, June 30th will be given a $0.255 dividend. This represents a $1.02 annualized dividend and a dividend yield of 0.8%. The ex-dividend date is Tuesday, June 30th. Agilent Technologies’s dividend payout ratio (DPR) is currently 20.48%.

Agilent Technologies Profile

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.